Benperidol is a high-potency antipsychotic drug from the butyrophenone class, first synthesized in the 1960s as an alternative to older neuroleptics like haloperidol. It was introduced primarily in Europe in the late 1960s and early 1970s, designed to provide strong antipsychotic effects with relatively fewer sedative side effects. Historically, it has also been used in forensic psychiatry to manage impulsive or aggressive behaviors. Clinically, benperidol is applied in the treatment of schizophrenia, particularly for patients needing potent antipsychotic therapy, and is effective in controlling acute psychotic episodes and severe agitation. Additionally, it has been employed to manage aggressive or violent behavior in institutionalized patients and for off-label control of hypersexual or impulsive behaviors. Benperidol is also used in long-term maintenance therapy to reduce relapse risk in chronic psychotic disorders. Its high potency and long duration of action make it valuable in specific psychiatric and forensic settings, although its use has declined with the advent of newer atypical antipsychotics.
